Skip to main content
. 2016 Nov 30;69(2):211–216. doi: 10.1016/j.ihj.2016.09.009

Table 4.

Drug therapies in acute coronary syndrome and stable IHD groups.

Evidence based drugs Total
997
n (%)
Acute coronary syndrome
680
n (%)
Stable IHD
317
n (%)
p value
Antiplatelet drugs 835 (83.7) 544(80.5) 291(91.8) <0.0001
ACE inhibitors/ARBs 413 (41.4) 244(35.9) 169 (53.3) <0.0001
Beta blockers 386 (38.7) 371(54.6) 15(4.7) <0.0001
Statins 637 (63.5) 549(80.8) 88(27.7) <0.0001